Inovio Pharmaceuticals, Inc. (INO)
$1.11-3.48%Close
SELLBEAR · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV5.1%–493.2%
- Market cap
- $59M
- Beta
- 1.61
- P/E (TTM)
- -0.97
- IV-%ile
- 1
- IV ATM
- 5.3%
- Short % float
- 39.05%
- Days to cover
- 7.6
- SI change
- +4.5%
- 1W
- -3.48%
- 1M
- -11.20%
- vs SPY 1W
- -3.90%
- vs SPY 1M
- -13.26%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on INO?
- LOPJLB’s latest quantitative signal on Inovio Pharmaceuticals, Inc. (INO) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is INO in?
- Inovio Pharmaceuticals, Inc. (INO) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Inovio Pharmaceuticals, Inc. (INO) do?
- Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely ide…